Ecolab Inc. research snapshot
ECL AI stock analysis reads Ecolab as a durable global water, hygiene, infection prevention and industrial efficiency franchise that is delivering accelerating growth. As of the August 2, 2026 data cutoff, the stock closed near $277.63 on July 31, 2026 with a market capitalization near $78.14 billion. The Q2 2026 report, released July 28, 2026, showed 5% organic sales growth, adjusted EPS of $2.09 up 11%, and a raise in the 2026 adjusted EPS outlook to $8.05 to $8.25. Ecolab also closed the CoolIT Systems acquisition on July 2, 2026 and now combines it with Ovivo Electronics, putting the Global High-Tech platform at roughly $1.5 billion in annualized sales tied to AI data center cooling and microelectronics. The setup is not a low-risk value signal because the stock trades near 37.3x trailing EPS and roughly 41.8x trailing free cash flow, with cash and investments near $5.1 billion but total debt near $13.8 billion after the CoolIT financing. The ECL AI stock forecast therefore uses scenario ranges rather than a precise price prediction, and it treats organic growth, pricing versus commodity costs, margin expansion, CoolIT and Ovivo integration, Middle East disruption and valuation multiples as the main drivers.
Current price
$277.63
Market cap
$78.14 billion verified market cap
AI score
73 / 100
Rating
Quality water, hygiene and high-tech compounder with accelerating growth and premium valuation risk
Trend status
Constructive but consolidating, above key moving averages and well below the 52-week high
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Ecolab sells mission-critical water, hygiene, infection prevention, pest elimination and process efficiency solutions to foodservice, hospitality, healthcare, manufacturing, life sciences and industrial customers, with an expanding data center cooling platform. | High |
| Moat | The moat comes from embedded service routes, switching costs, scale purchasing, application know-how, digital monitoring, brand trust, regulatory complexity, bioprocessing qualification barriers and customer savings from lower water, energy, waste and downtime. | High |
| Management | CEO Christophe Beck has pushed value pricing, digital subscriptions, life sciences scale and the CoolIT and Ovivo high-tech acquisitions, while the key test is whether higher leverage and integration costs at a premium multiple reward shareholders. | Medium-high |
| Financial trend | FY2025 sales were about $16.08 billion. Q2 2026 revenue rose to about $4.415 billion with 5% organic growth, adjusted EPS of $2.09 up 11%, and the full-year 2026 adjusted EPS outlook was raised to $8.05 to $8.25. | High |
| Valuation | At $277.63, ECL screens near 37.27x TTM EPS, 32.12x forward EPS, 4.64x sales, 7.75x book value, 41.75x TTM free cash flow, a 2.40% FCF yield and a 1.05% dividend yield. | High |
| Technical trend | The stock is above the 20-day moving average near $273.76, the 50-day near $268.43, the 100-day near $266.46 and the 200-day near $270.76, with 14-day RSI near 55 and a weak ADX near 16. | Medium |
| Risk level | Main risks are valuation compression, commodity cost inflation against pricing, Middle East volume disruption, CoolIT and Ovivo integration, higher debt after the acquisitions, customer budget pressure, FX and competition from specialized chemical and water-treatment providers. | Medium-high |
| AI confidence | Descriptive confidence is high because filings and third-party data are rich and the Q2 2026 release is fresh. Return confidence is lower because a quality business can still be a weak stock if the entry multiple is too demanding. | High data confidence |
| Investment certainty | ECL is a strong business, but the current price requires continued mid single-digit organic growth, margin gains, CoolIT and Ovivo integration and a durable premium multiple to create attractive upside. | Medium |
ECL AI stock forecast
The ECL AI stock forecast is scenario-based because the share price depends on organic growth, pricing versus commodity costs, operating leverage, CoolIT and Ovivo integration, Middle East disruption and the multiple investors assign to a high-quality specialty services business. Using the $277.63 price reference, the 2026 adjusted EPS guidance midpoint of $8.15, and a three-year model with 2%, 8% and 12% annual EPS growth and exit multiples of 24x, 30x and 36x, the mechanical range points to about $208 in a bear case, $308 in a base case and $412 in a bullish case before dividends. This is a valuation framework, not a guaranteed outcome.
$400 to $425 before dividends
More likely if EPS compounds near the low teens, CoolIT and Ovivo add credible AI data center cooling growth, organic sales stay near 5% to 7%, pricing stays ahead of input costs, margins expand toward the 20% operating margin target, debt stays manageable and investors keep valuing ECL above 34x earnings.
$295 to $320 before dividends
More likely if Ecolab delivers high single-digit adjusted EPS growth, 2026 adjusted EPS guidance near $8.05 to $8.25 is met, water, institutional and high-tech demand stay resilient, and the market values the company around a 30x forward multiple, broadly in line with the analyst consensus target near $324.67.
$195 to $220 before dividends
More likely if industrial demand slows, commodity costs outrun the 5% to 6% pricing path, the Middle East conflict widens, the CoolIT deal or debt load disappoints, or investors rerate the stock toward a low 20s earnings multiple.
ECL AI technical analysis
ECL AI technical analysis is constructive but consolidating as of the August 2, 2026 data cutoff. StockAnalysis listed the July 31, 2026 close near $277.63 and a $78.14 billion market cap, with a 52-week range of $243.15 to $309.27. Barchart showed price above the 20-day, 50-day, 100-day and 200-day moving averages, a 14-day RSI near 55 and a weak 14-day ADX near 16, which supports an uptrend but signals low trend conviction, so pullbacks into moving-average support matter more than chasing the current price.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $277.63 | StockAnalysis listed the July 31, 2026 close at $277.63 with a day range of $272.79 to $279.17. |
| Immediate support | $273 to $275 | The 20-day moving average near $273.76 from Barchart is the first short-term support for pullbacks. |
| Key support | $268 to $271 | The 50-day moving average near $268.43 and the 200-day near $270.76 cluster here and are the main trend-support zone. |
| Deeper support | $266 to $268 | The 100-day moving average near $266.46 from Barchart sits in this zone and marks a second line of defense. |
| Major support | $243 to $250 | This area sits near the 52-week low reference of $243.15 from StockAnalysis and is the level that would challenge the broader quality-compounder setup. |
| Near resistance | $279 to $282 | The 5-day moving average near $278.99 and recent price swings around $279 to $282 are the first test for buyers. |
| Secondary resistance | $288 to $290 | The early July 2026 swing-high zone is a stronger overhead level that needs volume to break. |
| Major resistance | $309 to $310 | The 52-week high near $309.27 is the main overhead level bulls need to clear for a new uptrend leg. |
| Moving averages | 20-day near $273.76, 50-day near $268.43, 100-day near $266.46, 200-day near $270.76 | Price is above all four averages, but the 200-day near $270.76 is close enough to price that a break would weaken the trend signal. |
| Momentum | RSI near 55, ADX near 16 | 14-day RSI near 55.03 is neutral and 14-day ADX near 16.13 shows a weak trend, so momentum does not yet confirm a strong directional move. |
| Volume | 20-day average near 1.2 million shares | Barchart and StockAnalysis show 20-day average volume near 1.2 million shares, so watch whether any breakout toward $288 to $290 comes with above-average volume. |
| Volatility | 14-day historic volatility near 26.5% | Barchart reported 14-day historic volatility near 26.5% and a 14-day ATR near $6.66, so position sizing should account for meaningful daily swings. |
| Invalidation | Close below $266, then below $243 | A sustained close below the 100-day and 50-day area near $266 to $268 would weaken the trend. A break below the 52-week low near $243 would challenge the larger quality-compounder setup. |
ECL AI trading strategy
The ECL AI trading strategy below is a rules-based research framework, not personal advice. It links chart levels with Q3 and full-year guidance, organic growth, pricing versus commodity costs, margin expansion, CoolIT and Ovivo integration, debt, Middle East disruption and water or high-tech demand indicators.
Watch for ECL to hold above the $268 to $275 moving-average support cluster and then break above $279 to $282 with constructive Q2 follow-through, stable guidance and no negative surprise on CoolIT or Ovivo integration plans.
A failed breakout followed by a close below $268 should reduce trend confidence, especially if guidance is lowered, pricing falls below the 5% to 6% second-half path, or volume weakens during the move.
If ECL pulls back toward $266 to $271 while 2026 adjusted EPS guidance and organic sales remain intact, compare the lower price with expected EPS growth, FCF yield, debt reduction and water or high-tech demand durability.
Do not treat a lower price as automatically attractive if the multiple stays above peer levels while growth slows, commodity costs rise or acquisition and leverage risk grows.
Track reported and organic sales growth, pricing versus commodity costs, segment margins, adjusted EPS guidance, free cash flow conversion, leverage, CoolIT and Ovivo contribution, data center cooling demand, Middle East disruption and institutional end-market health.
Position sizing should reflect that ECL is a premium-valued industrial services compounder with rising debt after acquisitions, not a guaranteed defensive bond substitute or a personalized portfolio recommendation.
Investment research summary
Customers pay Ecolab because clean water, safe food, reliable hygiene, pest-free environments, process uptime, infection prevention and lower energy or water use are operational necessities. The business converts specialized chemistry, service technicians, monitoring data and customer savings into recurring revenue.
Ecolab has strong customer switching costs, dense service networks, scale procurement, application knowledge, brand trust, regulatory complexity and digital monitoring. Life Sciences adds qualification barriers in bioprocessing, and CoolIT adds leading directed liquid cooling technology for AI data centers.
The thesis fails if commodity cost inflation outruns pricing, customers cut discretionary service scope, the Middle East disruption widens, CoolIT or Ovivo integration misses expectations, higher debt reduces flexibility, water projects slow or valuation multiples compress faster than EPS grows.
Christophe Beck has focused on value pricing, digital subscriptions, life sciences scale, high-tech demand and margin recovery, with CFO Scott Kirkland managing the balance sheet through the CoolIT financing. The capital allocation question is whether the CoolIT and Ovivo push into AI infrastructure cooling can justify the higher leverage and integration cost.
Water scarcity, food safety, healthcare hygiene, industrial efficiency, bioprocessing and AI data center cooling are long-duration themes. Ecolab is positioned in practical operating workflows and, with CoolIT and Ovivo, now claims an integrated position across the water, power and compute value chain.
The August 2, 2026 valuation offers limited obvious margin of safety. Company quality and growth momentum are high, but a 37.27x TTM EPS multiple and roughly 41.75x TTM free cash flow require sustained growth and a premium investor narrative, especially with total debt near $13.8 billion.
The bull case is that Ecolab compounds earnings through water scarcity, AI data center cooling, bioprocessing share gains, value pricing, service density, digital productivity and disciplined integration of CoolIT and Ovivo toward a $4 billion high-tech business by 2030.
The bear case is that a good business becomes a mediocre stock because commodity costs outrun pricing, growth slows, acquisition benefits arrive later than hoped, higher debt limits flexibility, Middle East disruption persists or the market refuses to pay a premium multiple for a specialty services compounder.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current price | $277.63 close on July 31, 2026 | StockAnalysis ECL market data | August 2, 2026 |
| Market capitalization | $78.14 billion, verified as $277.63 x 281.44 million shares with 0.00% deviation | financial_rigor.py market cap verification | August 2, 2026 |
| Q2 2026 revenue and EPS | Revenue about $4.415 billion, reported diluted EPS $1.90, adjusted diluted EPS $2.09 up 11% | Ecolab Q2 2026 earnings release via Business Wire | July 28, 2026 |
| Q2 2026 organic sales growth | 5% organic growth, 4% pricing, 1% volume, with about a 1% Middle East volume headwind | Ecolab Q2 2026 earnings call | July 28, 2026 |
| 2026 adjusted EPS guidance | $8.05 to $8.25, up 7% to 10%, raised from the prior $8.03 to $8.23 | Ecolab Q2 2026 earnings release and earnings call | July 28, 2026 |
| Q3 2026 adjusted EPS guidance | $2.13 to $2.23, up 3% to 8% from $2.07 a year ago | Ecolab Q2 2026 earnings call | July 28, 2026 |
| FY2025 revenue and TTM figures | FY2025 revenue $16.081 billion up 2.16%; TTM revenue $16.84 billion, TTM EPS $7.45 | StockAnalysis ECL financials | August 1, 2026 |
| Cash, debt and net debt | $5.135 billion cash and investments, $13.753 billion total debt, negative net cash of $8.618 billion as of June 30, 2026 | StockAnalysis ECL balance sheet | August 1, 2026 |
| TTM cash flow | Operating cash flow $3.03 billion, capital expenditures $1.16 billion, free cash flow $1.87 billion | StockAnalysis ECL cash flow statement | August 1, 2026 |
| CoolIT and Ovivo acquisitions | CoolIT Systems closed July 2, 2026 with year-to-date sales growth above 100%; Global High-Tech approaching $1.5 billion annualized sales | Ecolab Q2 2026 earnings call | July 28, 2026 |
| Valuation tool output | 37.27x PE, 32.12x forward PE, 4.64x PS, 7.75x PB, 41.75x P/FCF, 2.40% FCF yield, 1.05% dividend yield | financial_rigor.py using StockAnalysis and company data inputs | August 2, 2026 |
| Dividend | $2.92 annualized dividend, 1.05% yield, 40 years of growth | StockAnalysis ECL dividend data | August 1, 2026 |
| Analyst consensus | Buy rating across 26 analysts, average target $324.67, low $295, median $330, high $360 | StockAnalysis ECL forecast | July 31, 2026 |
| Analyst rating mix, July 2026 | 15 Strong Buy, 5 Buy, 6 Hold, 0 Sell out of 26 analysts | StockAnalysis ECL forecast recommendation trends | July 31, 2026 |
| Recent analyst target updates | BofA $342, UBS $342, BMO Capital $360, Morgan Stanley $330, Citi $330, Deutsche Bank $335, Mizuho $327, JPMorgan $305, Baird $305, Wells Fargo $295 | StockAnalysis ECL forecast and TipRanks | July 31, 2026 |
| 2026 and 2027 consensus estimates | FY2026 revenue estimate $17.96 billion with adjusted EPS $8.17, FY2027 revenue $19.30 billion with adjusted EPS $9.42 | StockAnalysis ECL forecast financial forecast | July 31, 2026 |
| Technical reference levels | 52-week high $309.27, 52-week low $243.15, 20-day moving average $273.76, 50-day $268.43, 100-day $266.46, 200-day $270.76, RSI near 55, ADX near 16 | Barchart and StockAnalysis ECL technical snapshots | July 31, 2026 |
This ECL AI stock analysis is an informational research tool only. It is not investment advice, financial advice or a recommendation to buy, sell or hold Ecolab Inc. Forecast scenarios are based on available data as of August 2, 2026 and can be wrong if fundamentals, valuation, technical conditions, commodity costs, acquisitions or market liquidity change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
